Further support for rituximab in relapsing multiple sclerosis. Naismith RT, Cross AH. Lancet Neurol 2022;21:672-673.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Naismith RT, Cross AH. Further support for rituximab in relapsing multiple sclerosis. Lancet Neurol 2022;21:672-673.
PMID: 35841895